Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;118:321-322
doi: 10.1161/CIRCULATIONAHA.108.189736
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles

(Circulation. 2008;118:321-322.)
© 2008 American Heart Association, Inc.

Clinical Summaries


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery
 
In this comprehensive review of the use of recombinant activated factor VII in nonhemophiliac patients who underwent cardiac surgery during the period 2003 through 2006 in Canada (n=503), we found that recombinant activated factor VII was used primarily when standard interventions had failed to control blood loss. Moreover, as far as could be determined within the confines of this observational study, we found that recombinant activated factor VII was associated with a reduction in transfusion of blood products and, after adjustment for patients’ underlying risk profile and red blood cell transfusion rate, did not appear to be associated with increased or decreased mortality or major morbidity. Finally, our data also suggested that the effectiveness of the drug may be enhanced if it is given early in the course of refractory blood loss in the setting of adequate amounts of circulating coagulation factors. Adequately powered randomized clinical trials are needed to verify these findings. See p 331.


*    {alpha}-Linolenic Acid and Risk of Nonfatal Acute Myocardial Infarction
 
Long-chain n-3 fatty acids from fish, eicosapentaenoic acid and docosahexaenoic acid, reduce cardiovascular mortality, but availability of fish is limited and probably insufficient to meet worldwide needs. {alpha}-Linolenic acid, an essential n-3 fatty acid found in vegetable cooking oils such as soybean and canola oils and other products of plant origin could be a viable alternative to fish oils. We determined whether {alpha}-linolenic acid was associated with risk of nonfatal acute myocardial infarction in 1819 case-control pairs from a population-based study in Costa Rica. Increased dietary {alpha}-linolenic acid assessed by questionnaire and in . . . [Full Text of this Article]


Related Articles:

Improved Survival After Out-of-Hospital Cardiac Arrest Is Associated With an Increase in Proportion of Emergency Crew–Witnessed Cases and Bystander Cardiopulmonary Resuscitation
Jacob Hollenberg, Johan Herlitz, Jonny Lindqvist, Gabriel Riva, Katarina Bohm, Mårten Rosenqvist, and Leif Svensson
Circulation 2008 118: 389-396. [Abstract] [Full Text]

Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Six-Year Follow-Up From the Stent or Surgery Trial (SoS)
Jean Booth, Tim Clayton, John Pepper, Fiona Nugara, Marcus Flather, Ulrich Sigwart, Rodney H. Stables on Behalf of the SoS Investigators
Circulation 2008 118: 381-388. [Abstract] [Full Text]

Mast Cells Play a Critical Role in the Pathogenesis of Viral Myocarditis
Hirokazu Higuchi, Masatake Hara, Kanjo Yamamoto, Tadashi Miyamoto, Makoto Kinoshita, Tasuku Yamada, Koji Uchiyama, and Akira Matsumori
Circulation 2008 118: 363-372. [Abstract] [Full Text]

Mechanisms of Preejection and Postejection Velocity Spikes in Left Ventricular Myocardium: Interaction Between Wall Deformation and Valve Events
Espen W. Remme, Erik Lyseggen, Thomas Helle-Valle, Anders Opdahl, Eirik Pettersen, Trond Vartdal, Asgrimur Ragnarsson, Morten Ljosland, Halfdan Ihlen, Thor Edvardsen, and Otto A. Smiseth
Circulation 2008 118: 373-380. [Abstract] [Full Text]

{alpha}-Linolenic Acid and Risk of Nonfatal Acute Myocardial Infarction
Hannia Campos, Ana Baylin, and Walter C. Willett
Circulation 2008 118: 339-345. [Abstract] [Full Text]

Comprehensive Canadian Review of the Off-Label Use of Recombinant Activated Factor VII in Cardiac Surgery
Keyvan Karkouti, W. Scott Beattie, Ramiro Arellano, Tim Aye, Jean S. Bussieres, Jeannie L. Callum, Davy Cheng, Lee Heinrich, Blaine Kent, Trevor W.R. Lee, Charles MacAdams, C. David Mazer, Brian Muirhead, Antoine G. Rochon, Fraser D. Rubens, Corey Sawchuk, Shaohua Wang, Terrence Waters, Bill I. Wong, and Terrence M. Yau
Circulation 2008 118: 331-338. [Abstract] [Full Text]

Aerobic Interval Training Versus Continuous Moderate Exercise as a Treatment for the Metabolic Syndrome: A Pilot Study
Arnt Erik Tjønna, Sang Jun Lee, Øivind Rognmo, Tomas O. Stølen, Anja Bye, Per Magnus Haram, Jan Pål Loennechen, Qusai Y. Al-Share, Eirik Skogvoll, Stig A. Slørdahl, Ole J. Kemi, Sonia M. Najjar, and Ulrik Wisløff
Circulation 2008 118: 346-354. [Abstract] [Full Text]

Alternative Splicing of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Is Associated With Plasma Low-Density Lipoprotein Cholesterol Response to Simvastatin
Marisa Wong Medina, Feng Gao, Weiming Ruan, Jerome I. Rotter, and Ronald M. Krauss
Circulation 2008 118: 355-362. [Abstract] [Full Text]